Attys Scratch Heads As FDA Punts Generic-Label Rule To 2017
The U.S. Food and Drug Administration on Thursday said that a new policy allowing generic-drug makers to unilaterally update their warning labels won't be finalized until 2017, adding to prior delays...To view the full article, register now.
Already a subscriber? Click here to view full article